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Abstract: Dendritic cells initiate and sustain immune responses by migrating to sites of 
pathogenic insult, transporting antigens to lymphoid tissues and signaling immune specific 
activation of T cells through the formation of the immunological synapse. Dendritic cells 
can also transfer intact, infectious HIV-1 to CD4 T cells through an analogous structure, 
the infectious synapse. This replication independent mode of HIV-1 transmission, known 
as trans-infection, greatly increases T cell infection in vitro and is thought to contribute to 
viral dissemination in vivo. This review outlines the recent data defining the mechanisms 
of trans-infection and provides a context for the potential contribution of trans-infection in 
HIV-1 disease. 
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1. Dendritic cells and immune control 
Dendritic cells (DCs) comprise a diverse family of cell types whose primary function is to 
coordinate innate and adaptive immune responses. Classical DCs, commonly referred to as myeloid 
DCs (mDC), are essential antigen presenting cells that patrol submucosal surfaces in search of 
pathogenic organisms and their antigens, which they bind and internalize using a variety of surface 
receptors. The DCs carry the intact pathogens and antigens to draining lymphoid tissues and degrade 
them into antigenic peptides that are loaded onto HLA Class II molecules for presentation to CD4
+ T 
cells [1]. In this capacity, mDCs act as a conduit between the periphery and lymphoid tissues to initiate 
immune control of mucosal infections. Langerhans cells (LC), also of the myeloid lineage, similarly 
act as sentinels of epidermal and mucosal epithelia, however they are largely confined to local sites of 
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infection within the epithelial layer where they sustain innate and adaptive immune responses. The 
third major subtype of circulating DCs, plasmacytoid DCs (pDCs), are thought to derive from the 
lymphoid lineage and are particularly effective at initiating early responses to viral infections. pDCs 
secrete large amounts of type-I interferons and pro-inflammatory cytokines, signaling the recruitment 
of DCs and other immune effectors to the site of pathogen invasion. While all three DC subsets play 
important roles in immune control and pathogenesis in HIV-1 infection, this review will focus on the 
myeloid subset of DCs because of their peculiar ability to both initiate immunity to HIV-1 and to 
exacerbate HIV-1 infection by passing the intact virus to the very T cells responding to the insult. The 
origins and functions of dendritic cells is reviewed in great detail elsewhere, most notably by 
Geissmann [2] and Steinman [3]. 
When mDCs encounter and engulf pathogens at the site of infection, they undergo a series of 
maturation events and emigrate to local lymph nodes. Maturation is accompanied by activation of 
antigen degradation and presentation, up-regulation of T cell co-stimulatory molecules, and near 
complete shutdown of macropinocytosis and phagocytosis [4]. Once in the lymph node, the DCs 
present antigen/MHC Class-II complexes to CD4
+ T cells to initiate adaptive immune responses to the 
pathogens they have carried from the periphery. Maturation freezes the expression of stabilized 
peptide/MHC-II complexes on the cell surface, prolonging presentation of peptides from antigens 
processed at the time of pathogen exposure, a model that has been termed the freeze-frame hypothesis. 
Because endocytosis is shut down, newly acquired antigens are not trafficked into the lysosomal 
degradative pathway for presentation, resulting in preferential presentation of antigens acquired at the 
site of peripheral tissue challenge [5-7]. 
When a CD4
+ T cell encounters a DC in the lymph node, adhesion molecules such as LFA-1 and 
ICAM-1 cause the cell to arrest its movement and probe the DC surface. If the DC presents the correct 
antigen peptide/MHC-II complexes, the T cell will respond by concentrating T cell receptors, CD4 and 
numerous other adhesive and signaling molecules to form a structure known as the immunological 
synapse [8,9]. Antigen recognition by the T cell receptor stabilizes DC-T cell contacts that can last for 
several hours, providing sustained signals to the T cell to induce activation and proliferation [10]. In 
the absence of antigen recognition, incomplete immunological synapses are formed that generate weak 
signals thought to sustain T cell viability without activating the cells. In this capacity, DCs can help 
maintain naïve and memory T cells prior to antigenic challenge [11].  
In addition to presentation of processed peptide antigens, DCs can transfer intact proteins and 
pathogens to other cells. In this capacity, DCs can transport antigens from sites of peripheral infection 
to lymphoid tissues, where they can pass them on to other antigen presenting cells and thereby enhance 
the breadth of immune responses [12]. DCs can also present intact antigens to B cells in lymphoid 
tissues to stimulate antigen specific proliferation and antibody secretion [13]. Both of these processes 
are mediated by endocytic uptake of antigens and accumulation into late endosomal structures known 
as multivesicular bodies or endosomes (MVB/MVE). MVBs are formed by inward budding of 
endosomes to the limiting membrane, resulting in the accumulation of “inside-out” endosomes 
approximately 50 nm in diameter called exosomes. After antigen uptake, MVBs can either traffic into 
the degradative lysosomal system to feed the antigen processing pathway or they can be routed back to 
the surface, where they deliver surface receptors back to the plasma membrane and excrete exosomes 
out of the cell (reviewed in [14,15]). Viruses 2010, 2                  
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2. Role of dendritic cells in viral dissemination 
Because of their crucial role in initiating innate and adaptive immune responses, DCs are often 
specifically targeted by viruses in what can be thought of as a form of offensive immune evasion. For 
example, mouse mammary tumor virus (MMTV), a milk transmitted retrovirus that ultimately infects 
mammary epithelial cells, establishes its initial reservoir in the gut of suckling mice by directly 
infecting DCs, which then carry the virus to lymphatic tissues. In the lymph node, the infected DCs 
activate T cells, which provide activating signals to DCs, B- and T cells. The activated lymphocytes 
and DCs provide a reservoir of infected and infection competent cells, which then carry the virus to 
mammary tissues. Importantly, ablation of dendritic cells prior to MMTV exposure blocks initial 
infection and DC ablation during ongoing MMTV infection attenuates the replication of the virus, 
indicating that DCs are likely involved both in initiating infectious events as well as ongoing viral 
amplification and dissemination throughout the course of infection [16,17]. Dendritic cells are targeted 
by numerous other viruses, either by direct infection or by immune modulation, often targeting the 
innate responses that are critical for DC mediated immune control. Herpesviruses, Papilloma and Foot-
and-mouth disease viruses have all been shown to modulate DC function in order to enhance viral 
transmission and pathogenicity (reviewed in [18]). It is not surprising, then, that HIV-1 may have 
developed means to exploit dendritic cell mediated immune functions. 
Because DCs reside in submucosal tissues, they are thought to be among the first cells that 
encounter HIV following sexual transmission. The three major types of tissue dendritic cells play 
distinct roles in HIV infection. Langerhans cells are susceptible to HIV-1 infection in vitro and can 
initiate robust infection of memory CD4 T cells [19,20], however LC appear to be largely resistant to 
HIV-1 infection and may instead act to bind and degrade the majority of incoming virions in the 
subepithelium [21]. Plasmacytoid DCs respond to localized HIV-1 infection in the submucosa and 
initiate inflammatory responses and recruitment of immune cells, and in particular CD4 T cells, which 
may fuel the early expansion of HIV-1 [22]. In addition, pDCs appear to be a major source of type 1 
interferons that drive immune activation during pathogenic Simian Immunodeficiency Virus (SIV) 
infection [23].  
Myeloid DCs are particularly resistant to infection by HIV-1 in vitro and productively infected 
mDCs have not been identified in infected individuals, likely due to their innate resistance to infection 
[24,25]. Interestingly, HIV-2 and SIV can overcome this innate resistance to infection by incorporation 
of viral vpx proteins into the virion core [26], and HIV-1 infection can be rescued by delivery of vpx 
into DCs by co-incubation with HIV-2/SIV viral-like particles, suggesting that vpx can counteract an 
antiviral restriction present in DCs [25]. The consequences of DC infection by SIV/HIV-2 has not yet 
been studied in detail, though it will no doubt provide insight into the contributions of cis- and trans-
infections  in vivo. The remainder of this review, however, will focus primarily on replication 
independent trans-infection by mDCs. 
Myeloid dendritic cells were first implicated in HIV-1 pathogenesis nearly two decades ago when it 
was found that HIV-1 exposed DCs could greatly stimulate infection without first becoming infected 
and that purified DCs could nucleate clusters of CD4
+ T cells and drive their infection in vitro [27,28]. 
These early studies suggested that HIV-1 could take advantage of the partnership between CD4 T cells 
and DCs, providing a microenvironment harboring infectious HIV-1 while at the same time increasing Viruses 2010, 2                  
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T cell susceptibility to infection. A key insight into the mechanism of HIV-1 transfer by DCs was the 
identification DC-SIGN (DC-specific ICAM-3 grabbing non-integrin, CD209), a C-type lectin 
receptor (CLR) that binds the HIV-1 envelope glycoprotein gp120 with high affinity [29]. DC-SIGN is 
known to function as an important adhesion receptor in DC trafficking and immune synapse formation 
and can also act to capture and internalize soluble antigens [30,31]. Surprisingly, when HIV-1 is bound 
by DC-SIGN, the virus remains infectious and can be efficiently transmitted to target cells without first 
replicating in the DC. This replication-independent transfer, referred to as trans-infection, requires 
gp120/CD4 mediated fusion into target cells, indicating that the virus must remain fully intact within 
the DCs. It has since become apparent that numerous factors can mediate or modulate trans-infection, 
including other C-type lectin receptors (CLRs) [32,33], heparin-sulphate binding syndecans [34] and 
even glycosphingolipid content of the virus [35].  
3. HIV-1 trans-infection at the infectious synapse 
Initial studies using in vitro cultured monocytes-derived dendritic cells (MDDCs) and cell lines 
expressing DC-SIGN demonstrated that DCs could sequester infectious HIV-1 for several days after 
uptake, leading to the hypothesis that DCs might initiate primary infections by carrying HIV-1 from 
mucosal sites of exposure to lymphoid tissues and transferring infection to CD4 T cells in the lymph 
node [29]. Moreover, the virus appeared to be sequestered within a protease resistant, endosomal 
compartment and trafficked back out of the cell prior to trans-infection [36], suggesting that HIV-1 
could hide from the extracellular milieu within the DC and re-emerge on encounter with a target cell, a 
model referred to as the “Trojan horse” hypothesis. Direct visualization using GFP-tagged HIV-1 
revealed that DCs trans-infect HIV-1 by binding and concentrating the intact virus at the cellular 
interface and at the same time induce recruitment of HIV-1 receptors CD4, CXCR4 and CCR5 on the 
T cell, forming a structure analogous to the immunological synapse and therefore called the infectious 
synapse [37]. A subsequent study demonstrated that infected T cells can transfer HIV-1 to other CD4 T 
cells by forming a similar structure, the virological synapse [38]. An important distinction between 
these two forms of contact mediated transmission is that virological synapse formation requires 
interaction of HIV-1 envelope glycoprotein on the infected cell surface with CD4 on the target, 
whereas DC trans-infection relies on adhesion molecules utilized during natural immune interactions 
[38-40]. DCs can be infected in vitro, albeit with very low efficiency, in which case HIV-1
 gp120 
dependent virological synapse formation results in cis-infection of T cells [41,42]. HIV-1 transmission 
in  cis-  and trans- appear to utilize similar but distinct pathways in DCs [43,44], an important 
consideration when evaluating experimental results that do not distinguish the two possibilities. 
Early studies demonstrated that prior maturation of the DCs with lipopolysaccharide (LPS) and 
other activators markedly enhances infectious synapse formation and concomitant trans-infection  
[37,45]. Indeed, immature DCs rapidly endocytose and degrade HIV-1 and may not harbor intact virus 
long enough to carry it to lymphatic tissues, as originally hypothesized [41,46]. Immature DCs 
efficiently present processed HIV-1 antigens to CD4
+ T cells, indicating that HIV-1 does not subvert 
the Class II processing pathway in dendritic cells [47]. DC-SIGN and other scavenger receptors, 
therefore, appear to be primarily involved in virus uptake, endocytosis and degradation in immature 
DCs, and trans-infection may be a byproduct of incomplete internalization. LPS matured DCs, on the Viruses 2010, 2                  
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other hand, have greatly diminished capacity to degrade and present newly bound HIV-1 due to down-
modulation of the endo-lysosomal system. Instead, mature DCs concentrate HIV-1 into a single 
compartment originally identified as an unconventional endocytic compartment rich in the tetraspanin 
CD81, a marker of multivesicular endosomes/MVBs, and lacking lysosomal/degradative markers such 
as CD63 and LAMP-1 [48]. A number of studies supported the notion that mature DCs sequester intact 
HIV-1 within an intracellular, MVB-like endosome that is protected from the extracellular mileau, and 
delivery to T cells at the infectious synapse is routed through the MVB/exocytosis pathway [49-52] 
(Figure 1). A conflicting study, however, suggested that HIV-1 contained within endosomes could not 
participate in trans-infection. Warner Greene’s group convincingly demonstrated that trans-infected 
HIV-1 was fully sensitive to surface-applied soluble CD4 (sCD4) even after the virus was sequestered 
within the DCs [53]. While it was already known that fusion inhibitors could block trans-infection 
when present during co-culture, this study showed that the virus was inactivated even when sCD4 was 
applied after HIV-1 binding and sequestration and washed away before co-culture. The inhibitors were 
added at 4 C to prevent endocytosis, and therefore membrane impermeable inhibitors like sCD4 could 
not access endocytic compartments and should not be able to inhibit the sequestered HIV-1. 
Nevertheless,  trans-infection was completely blocked, leading the authors to conclude that only 
surface-bound virions participated in trans-infection. Surface inhibition was demonstrated over a large 
range of input virus in trans-infection mediated by either immature or mature DCs. Intriguingly, a 
small amount of surface sCD4-resistant trans-infection occurred when antigen recognition was 
mimicked using Staphylococcus enterotoxin, however even under those conditions greater than 90% of 
virus transfer was inhibited. The authors concluded, therefore, that trans-infected HIV-1 was primarily 
derived from surface-bound virions, and that the sequestered, internalized HIV-1 was “dead-end” virus 
bound for degradation [53]. 
This was a surprising conclusion that conflicted with the fluorescent imaging data, and so we 
undertook a careful re-examination of trans-infection by mature DCs in light of these results [54]. 
Using time-lapse microscopy, we showed that the sequestered HIV-1 was rapidly recruited to sites of 
T cell contact, and individual particles trafficked out of the HIV-1 containing compartment and entered 
the T cell at the infectious synapse. Importantly, after transmission the virus rapidly fused into the T 
cell cytoplasm, directly demonstrating that HIV-1 delivery from intracellular stores resulted in 
productive entry of the viral particles at the infectious synapse. Remarkably, we found that although 
the sequestered HIV-1 appeared to be contained within intracellular compartments in the DCs, the 
structure remained contiguous with the cell surface and distinct from endocytic vesicles. Using several 
different membrane impermeable protein and lectin probes, we demonstrated that the HIV-1 residing 
within the DCs remained accessible to surface-applied ligands and that the compartment appeared to 
be comprised of invaginated plasma membrane folds. Therefore when inhibitors like sCD4 were added 
to the DCs it accessed the sequestered, “intracellular” HIV-1 and inactivated it. Importantly, if the DCs 
were fixed prior to application of the probes, the sequestered HIV-1 became inaccessible unless 
cellular membranes were first removed with detergent, suggesting that formaldehyde fixation “closed” 
the access to the surface-applied probes and that the connection to the surface was restricted in size. 
This is likely the reason we and others had concluded that the sequestered virus was contained within 
intracellular, endosomal compartments. Our results showed that the HIV-1 was in fact transferred from 
an internalized, endosome-like structure, however the structure remained connected to the cell surface, Viruses 2010, 2                  
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rendering the virus susceptible to surface-applied inhibitors [54]. Langerhans dendritic cells (LCs) 
appear to trans-infect HIV-1 through similar surface-exposed structures [53,55], however there is 
some conflicting evidence suggesting that LCs are protected from infection by expression of the CLR 
Langerin [21]. 
Figure 1. HIV-1 is sequestered into a distinct subcellular compartment in mature dendritic 
cells. A-B. Distribution of HIV-1 (green) in immature (a) and LPS matured (b) MDDCs. 
Images are whole cell volume rendered z-stacks, actin cytoskeleton (red) nuclear DNA 
(blue). C-D. Fluorescent 3D (c) and single z-plane (d) images of a mature DC harboring 
HIV-1 (green) stained for MHC-II (blue) and CD86 (red). Inset (d) shows magnified HIV-
1 compartment. Bars, 5 µm. 
 
 
Similar structures have been described in productively infected macrophages, which concentrate 
HIV-1 in CD81-positive compartments originally identified as late endosome/MVBs [56]. EM analysis 
revealed that the HIV-1-containing compartments in macrophages consist of a network of invaginated 
structures contiguous with the plasma membrane and accessible by surface applied, membrane 
impermeant probes [57,58]. Three dimensional reconstruction of serial EM sections showed that the 
virus was contained within surface-derived membrane folds [59] that appear surprisingly similar to 
structures that can be observed in mature DCs (Figure 2). Interestingly, sequestered HIV-1 is rapidly Viruses 2010, 2                  
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translocated to the virological synapse formed between infected macrophages and uninfected T cells 
[60], further suggesting commonality between macrophage and DC mediated HIV-1 transmission.  
Figure 2. HIV-1 is trapped within surface-accessible membrane invaginations. a. Thin 
section transmission electron micrograph of a mature DC with HIV-1 particles trapped 
within apparent membrane folds. Cells were pulsed with HIV-1
LAI, fixed, prepared and 
sectioned for TEM. b. Magnified view of boxed area in a. Bars, 1 µm (a), .2 µm (b). 
 
 
Taken together, these data suggest that immature dendritic cells efficiently endocytose, degrade 
and present HIV-1 antigens, and that trans-infection by immature DCs is a consequence of residual 
virus that remains on the cell surface. Mature DCs, on the other hand, have diminished capacity to 
endocytose the virus and instead form pocket-like compartment in DCs in order to remove infectious 
virions from the cell surface and to maintain them in an intact form during transport and delivery to 
other antigen presenting cells in lymphoid tissues. As a consequence, infectious HIV-1 can be 
delivered to CD4 T cells during immune presentation, resulting in inadvertent dissemination by the 
DCs (Figure 3). Intriguingly, our high-resolution imaging of DC-T cell conjugates suggests that the T 
cells may participate in trans-infection by extending membrane protrusions into the virus-containing 
pocket. Moreover, while both CD8 and CD4 T cells can extend these protrusions, virus particles 
transferred only into the CD4 cells, suggesting that HIV-1 can engage CD4 on the T cell protrusions to 
emerge from the pocket, consistent with the observation that contact with CD4 T cells facilitates the 
release of HIV from DCs at the infectious synapse whereas CD8 T cells does not [61]. These results 
could explain why HIV-1 egress from the pocket structure is relatively inefficient, however once it 
leaves the pocket the virus rapidly fuses into the T cell. The interacting T cells may play an important 
role in fishing the virus out of the pocket, and CD4 engagement of HIV-1
 gp120 on the virion could 
favor trafficking along the T cell protrusions. HIV-1 uses the actin/myosin machinery to move on 
similar structures, referred to as cytonemes or nanotubes, during transmission from infected cells, 
[62,63], further suggesting there may be a common link between the virological and infectious 
synapses. Viruses 2010, 2                  
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Figure 3. Models of immature and mature DC mediated trans-infection. a. The majority of 
HIV-1 bound by immature DCs is endocytosed, processed and presented as   
MHC-II/peptide complexes. HIV-1 remaining on the DC surface can be transmitted at the 
infectious synapse. b. Mature DCs concentrate viral particles within membrane folds.   
HIV-1 can emerge from the pocket structure after engaging CD4 on interacting T cells. 
CLR, C-type lectin receptor; CK-R, Chemokine receptor. Adapted from [54]. 
 
 
4. HIV-1 dissemination in lymphoid tissues 
In recent years there has been a paradigm shift in our understanding of HIV pathogenesis, stemming 
from the recognition that the earliest targets of infection are mucosal memory CD4
+ T cells. Simian 
models of HIV infection demonstrated that the virus establishes its initial reservoirs of infection in 
resting T cells of the gut associated lymphoid tissue (GALT), and subsequent immune activation due 
to damage to the gut establishes rampant infection and depletion of CD4
+ T cells [64-66]. Similar 
massive T cell loss can be observed in biopsies of gut tissue from HIV-1-infected individuals [67]. In 
the SIV/macaque model, the earliest detectable targets of infection during vaginal transmission appear 
to be resting CD4 T cells in the lamina propria underlying the genital mucosa [64]. Plasmacytoid DCs 
(pDCs) appear to be the first cells that respond to infection in the lamina propria, and abrogating their 
recruitment can be protective to vaginal challenge [22]. Moreover, innate responses mediated primarily 
by pDCs distinguishes pathogenic and nonpathogenic SIV infections [23]. A potent immune response 
to primary infection therefore does not result in clearance of HIV-1 infection, but rather provides an 
ideal environment for establishing chronic infection, which in turn drives mucosal dendritic cells into 
lymphoid tissues and provides additional stimulus for viral amplification [68]. Activated DCs can 
amplify HIV-1 infection within lymphoid tissues by continually picking up and trans-infecting HIV-1 
during the ongoing immune battle, and preferential infection of HIV-1 specific CD4 T cells may be a 
consequence of stabilized DC-T cell immune synapse formation leading to increased opportunity to 
pass on HIV-1 infection, resulting in their accelerated depletion and consequent failure to control 
infection [69,70]. Viruses 2010, 2                  
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5. Conclusions  
DCs play a critical role in the establishment and persistence of viral infection in HIV disease. 
Because of their pivotal role in initiating immune responses, DC based immune therapies have been 
widely studied as potential therapeutic and vaccine vectors. Before DC therapies can be applied, 
however, it is essential to fully appreciate the role they play in HIV-1 dissemination. Clearly, trans-
infection is an undesirable byproduct of viral clearance by DCs.  
Chronic immune activation is a hallmark of HIV-1 infection, ultimately resulting in immune 
collapse and failure to control opportunistic infections. During the course of disease, the human 
immune system engages in a pitched battle with the virus, however the potent CD4
+ T cell responses 
that are elicited are the very thing that provides the fuel for HIV-1 infection. The resultant downward 
spiral of CD4
+ T cells ultimately leads to collapse of T cell populations and complete immune system 
failure. Strategies to boost immune control of HIV-1, therefore, must be directed at intervention of 
viral spread in the responding T cells, giving them a fighting chance to control viremia. In the course 
of a single day, one DC can interact with dozens of T cells in a lymph node, providing ample 
opportunity to transmit HIV-1 to either antigen-activated or quiescent T cells. Therefore, DCs can act 
as a replication-independent viral reservoir that is protected from attack both by current anti-viral drug 
regimens and by the host defense systems. There appears to be a dynamic balance between antigen 
processing and trans-infection in DCs, and putting the brakes on trans-infection may be one way to 
shift the balance to favor immune control of HIV-1 disease. 
References and Notes 
1.  Banchereau, J.; Briere, F.; Caux, C.; Davoust, J.; Lebecque, S.; Liu, Y.J.; Pulendran, B.; Palucka, 
K. Immunobiology of dendritic cells. Annu. Rev. Immunol. 2000, 18, 767-811. 
2.  Geissmann, F.; Manz, M.G.; Jung, S.; Sieweke, M.H.; Merad, M.; Ley, K. Development of 
monocytes, macrophages, and dendritic cells. Science 2010, 327, 656-661. 
3.  Steinman, R.M.; Idoyaga, J. Features of the dendritic cell lineage. Immunol. Rev. 2010, 234, 5-17. 
4.  Garrett, W.S.; Chen, L.M.; Kroschewski, R.; Ebersold, M.; Turley, S.; Trombetta, S.; Galan, J. E.; 
Mellman, I. Developmental control of endocytosis in dendritic cells by Cdc42. Cell 2000, 102, 
325-334. 
5.  Cella, M.; Engering, A.; Pinet, V.; Pieters, J.; Lanzavecchia, A. Inflammatory stimuli induce 
accumulation of MHC class II complexes on dendritic cells. Nature 1997, 388, 782-787. 
6.  Askew, D.; Chu, R.S.; Krieg, A.M.; Harding, C.V. CpG DNA induces maturation of dendritic 
cells with distinct effects on nascent and recycling MHC-II antigen-processing mechanisms.   
J. Immunol. 2000, 165, 6889-6895. 
7.  Pai, R.K.; Askew, D.; Boom, W.H.; Harding, C.V. Regulation of class II MHC expression in 
APCs: roles of types I, III, and IV class II transactivator. J. Immunol. 2002, 169, 1326-1333. 
8.  Monks, C.R.; Freiberg, B.A.; Kupfer, H.; Sciaky, N.; Kupfer, A. Three-dimensional segregation 
of supramolecular activation clusters in T cells. Nature 1998, 395, 82-86. Viruses 2010, 2                  
 
 
1713
9.  Grakoui, A.; Bromley, S.K.; Sumen, C.; Davis, M.M.; Shaw, A.S.; Allen, P.M.; Dustin, M.L. The 
immunological synapse: a molecular machine controlling T cell activation. Science 1999, 285, 
221-227. 
10.  Sumen, C.; Mempel, T.R.; Mazo, I. B.; von Andrian, U.H. Intravital Microscopy: Visualizing 
Immunity in Context. Immunity 2004, 21, 315-329. 
11.  Revy, P.; Sospedra, M.; Barbour, B.; Trautmann, A. Functional antigen-independent synapses 
formed between T cells and dendritic cells. Nat. Immunol. 2001, 2, 925-931. 
12.  Denzer, K.; van Eijk, M.; Kleijmeer, M.J.; Jakobson, E.; de Groot, C.; Geuze, H.J. Follicular 
dendritic cells carry MHC class II-expressing microvesicles at their surface. J. Immunol. 2000, 
165, 1259-1265. 
13.  Qi, H.; Egen, J.G.; Huang, A.Y.; Germain, R.N. Extrafollicular activation of lymph node B cells 
by antigen-bearing dendritic cells. Science 2006, 312, 1672-1676. 
14.  Denzer, K.; Kleijmeer, M.J.; Heijnen, H.F.; Stoorvogel, W.; Geuze, H. J. Exosome: from internal 
vesicle of the multivesicular body to intercellular signaling device. J. Cell. Sci. 2000, 113 Pt 19, 
3365-3374. 
15.  Thery, C.; Zitvogel, L.; Amigorena, S. Exosomes: composition, biogenesis and function. Nat. Rev. 
Immunol. 2002, 2, 569-579. 
16.  Courreges, M.C.; Burzyn, D.; Nepomnaschy, I.; Piazzon, I.; Ross, S.R. Critical role of dendritic 
cells in mouse mammary tumor virus in vivo infection. J. Virol. 2007, 81, 3769-3777. 
17. Ross, S.R. MMTV Infectious Cycle and the Contribution of Virus-encoded Proteins to 
Transformation of Mammary Tissue. J. Mammary Gland Biol. Neoplasia 2008, 13, 299-307. 
18. Golde, W.T.; Nfon, C.K.; Toka, F.N. Immune evasion during foot-and-mouth disease virus 
infection of swine. Immunol. Rev. 2008, 225, 85-95. 
19. Blauvelt, A.; Glushakova, S.; Margolis, L.B. HIV-infected human Langerhans cells transmit 
infection to human lymphoid tissue ex vivo. Aids 2000, 14, 647-651. 
20. Sugaya, M.; Lore, K.; Koup, R.A.; Douek, D.C.; Blauvelt, A. HIV-infected Langerhans cells 
preferentially transmit virus to proliferating autologous CD4+ memory T cells located within 
Langerhans cell-T cell clusters. J. Immunol. 2004, 172, 2219-2224. 
21.  de Witte, L.; Nabatov, A.; Pion, M.; Fluitsma, D.; de Jong, M.A.; de Gruijl, T.; Piguet, V.; van 
Kooyk, Y.; Geijtenbeek, T.B. Langerin is a natural barrier to HIV-1 transmission by Langerhans 
cells. Nat. Med. 2007, 13, 367-371. 
22. Li, Q.; Estes, J.D.; Schlievert, P.M.; Duan, L.; Brosnahan, A.J.; Southern, P.J.; Reilly, C.S.; 
Peterson, M.L.; Schultz-Darken, N.; Brunner, K.G.; Nephew, K.R.; Pambuccian, S.; Lifson, J. D.; 
Carlis, J.V.; Haase, A.T. Glycerol monolaurate prevents mucosal SIV transmission. Nature 2009, 
458, 1034-1038. 
23.  Mandl, J.N.; Barry, A.P.; Vanderford, T.H.; Kozyr, N.; Chavan, R.; Klucking, S.; Barrat, F.J.; 
Coffman, R.L.; Staprans, S.I.; Feinberg, M.B. Divergent TLR7 and TLR9 signaling and type I 
interferon production distinguish pathogenic and nonpathogenic AIDS virus infections. Nat. Med. 
2008, 14, 1077-1087. 
24.  Pion, M.; Granelli-Piperno, A.; Mangeat, B.; Stalder, R.; Correa, R.; Steinman, R.M.; Piguet, V. 
APOBEC3G/3F mediates intrinsic resistance of monocyte-derived dendritic cells to HIV-1 
infection. J. Exp. Med. 2006, 203, 2887-2893. Viruses 2010, 2                  
 
 
1714
25. Goujon, C.; Arfi, V.; Pertel, T.; Luban, J.; Lienard, J.; Rigal, D.; Darlix, J.L.; Cimarelli, A. 
Characterization of simian immunodeficiency virus SIVSM/human immunodeficiency virus type 
2 Vpx function in human myeloid cells. J. Virol. 2008, 82, 12335-12345. 
26.  Goujon, C.; Riviere, L.; Jarrosson-Wuilleme, L.; Bernaud, J.; Rigal, D.; Darlix, J.L.; Cimarelli, A. 
SIVSM/HIV-2 Vpx proteins promote retroviral escape from a proteasome-dependent restriction 
pathway present in human dendritic cells. Retrovirology 2007, 4, 2. 
27.  Cameron, P.U.; Freudenthal, P.S.; Barker, J.M.; Gezelter, S.; Inaba, K.; Steinman, R.M. Dendritic 
cells exposed to human immunodeficiency virus type-1 transmit a vigorous cytopathic infection to 
CD4+ T cells. Science 1992, 257, 383-387. 
28.  Pope, M.; Betjes, M.G.; Romani, N.; Hirmand, H.; Cameron, P.U.; Hoffman, L.; Gezelter, S.; 
Schuler, G.; Steinman, R.M. Conjugates of dendritic cells and memory T lymphocytes from skin 
facilitate productive infection with HIV-1. Cell 1994, 78, 389-398. 
29.  Geijtenbeek, T.B.; Kwon, D.S.; Torensma, R.; van Vliet, S.J.; van Duijnhoven, G.C.; Middel, J.; 
Cornelissen, I.L.; Nottet, H.S.; KewalRamani, V.N.; Littman, D.R.; Figdor, C.G.; van Kooyk, Y. 
DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. 
Cell 2000, 100, 587-597. 
30.  Geijtenbeek, T.B.; Engering, A.; Van Kooyk, Y. DC-SIGN, a C-type lectin on dendritic cells that 
unveils many aspects of dendritic cell biology. J. Leukoc. Biol. 2002, 71, 921-931. 
31.  Geijtenbeek, T.B.; Torensma, R.; van Vliet, S.J.; van Duijnhoven, G.C.; Adema, G.J.; van Kooyk, 
Y.; Figdor, C.G Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that 
supports primary immune responses. Cell 2000, 100, 575-585. 
32.  Turville, S.G.; Arthos, J.; Donald, K.M.; Lynch, G.; Naif, H.; Clark, G.; Hart, D.; Cunningham, 
A.L. HIV gp120 receptors on human dendritic cells. Blood 2001, 98, 2482-2488. 
33. Lambert, A.A.; Gilbert, C.; Richard, M.; Beaulieu, A.D.; Tremblay, M.J. The C-type lectin 
surface receptor DCIR acts as a new attachment factor for HIV-1 in dendritic cells and contributes 
to trans- and cis-infection pathways. Blood 2008, 112, 1299-1307. 
34.  de Witte, L.; Bobardt, M.; Chatterji, U.; Degeest, G.; David, G.; Geijtenbeek, T. B.; Gallay, P 
Syndecan-3 is a dendritic cell-specific attachment receptor for HIV-1. Proc. Natl. Acad. Sci.   
U. S. A. 2007, 104, 19464-19469. 
35.  Hatch, S.C.; Archer, J.; Gummuluru, S. Glycosphingolipid composition of human 
immunodeficiency virus type 1 (HIV-1) particles is a crucial determinant for dendritic cell-
mediated HIV-1 trans-infection. J. Virol. 2009, 83, 3496-3506. 
36. Kwon, D.S.; Gregorio, G.; Bitton, N.; Hendrickson, W.A.; Littman, D.R. DC-SIGN-mediated 
internalization of HIV is required for trans- enhancement of T cell infection. Immunity 2002, 16, 
135-144. 
37.  McDonald, D.; Wu, L.; Bohks, S.M.; KewalRamani, V.N.; Unutmaz, D.; Hope, T.J. Recruitment 
of HIV and its receptors to dendritic cell-T cell junctions. Science 2003, 300, 1295-1297. 
38.  Jolly, C.; Kashefi, K.; Hollinshead, M.; Sattentau, Q.J. HIV-1 cell to cell transfer across an Env-
induced, actin-dependent synapse. J. Exp. Med. 2004, 199, 283-293. Viruses 2010, 2                  
 
 
1715
39.  Puigdomenech, I.; Massanella, M.; Izquierdo-Useros, N.; Ruiz-Hernandez, R.; Curriu, M.; Bofill, 
M.; Martinez-Picado, J.; Juan, M.; Clotet, B.; Blanco, J. HIV transfer between CD4 T cells does 
not require LFA-1 binding to ICAM-1 and is governed by the interaction of HIV envelope 
glycoprotein with CD4. Retrovirology 2008, 5, 32. 
40.  Wang, J.H.; Kwas, C.; Wu, L. Intercellular adhesion molecule 1 (ICAM-1), but not ICAM-2 and -
3, is important for dendritic cell-mediated human immunodeficiency virus type 1 transmission.  
J. Virol. 2009, 83, 4195-4204. 
41.  Turville, S.G.; Santos, J.J.; Frank, I.; Cameron, P.U.; Wilkinson, J.; Miranda-Saksena, M.; Dable, 
J.; Stossel, H.; Romani, N.; Piatak, M., Jr.; Lifson, J.D.; Pope, M.; Cunningham, A.L. 
Immunodeficiency virus uptake, turnover, and 2-phase transfer in human dendritic cells. Blood 
2004, 103, 2170-2179. 
42.  Nobile, C.; Petit, C.; Moris, A.; Skrabal, K.; Abastado, J.P.; Mammano, F.; Schwartz, O. Covert 
human immunodeficiency virus replication in dendritic cells and in DC-SIGN-expressing cells 
promotes long-term transmission to lymphocytes. J. Virol. 2005, 79, 5386-5399. 
43. Garcia, E.; Nikolic, D.S.; Piguet, V. HIV-1 replication in dendritic cells occurs through a 
tetraspanin-containing compartment enriched in AP-3. Traffic 2008, 9, 200-214. 
44.  Turville, S.G.; Aravantinou, M.; Stossel, H.; Romani, N.; Robbiani, M. Resolution of de novo 
HIV production and trafficking in immature dendritic cells. Nat. Methods 2008, 5, 75-85. 
45.  Sanders, R.W.; De Jong, E.C.; Baldwin, C.E.; Schuitemaker, J.H.; Kapsenberg, M.L.; Berkhout, 
B. Differential transmission of human immunodeficiency virus type 1 by distinct subsets of 
effector dendritic cells. J. Virol. 2002, 76, 7812-7821. 
46.  Moris, A.; Nobile, C.; Buseyne, F.; Porrot, F.; Abastado, J.P.; Schwartz, O. DC-SIGN promotes 
exogenous MHC-I-restricted HIV-1 antigen presentation. Blood 2004, 103, 2648-2654. 
47.  Jones, L.; McDonald, D.; Canaday, D.H. Rapid MHC-II antigen presentation of HIV type 1 by 
human dendritic cells. AIDS Res. Hum. Retroviruses. 2007, 23, 812-816. 
48.  Garcia, E.; Pion, M.; Pelchen-Matthews, A.; Collinson, L.; Arrighi, J.F.; Blot, G.; Leuba, F.; 
Escola, J.M.; Demaurex, N.; Marsh, M.; Piguet, V. HIV-1 trafficking to the dendritic cell-T-cell 
infectious synapse uses a pathway of tetraspanin sorting to the immunological synapse. Traffic 
2005, 6, 488-501. 
49.  Wiley, R.D.; Gummuluru, S. Immature dendritic cell-derived exosomes can mediate HIV-1 trans 
infection. Proc. Natl. Acad. Sci. U. S. A. 2006, 103, 738-743. 
50.  Izquierdo-Useros, N.; Blanco, J.; Erkizia, I.; Fernandez-Figueras, M.T.; Borras, F.E.; Naranjo-
Gomez, M.; Bofill, M.; Ruiz, L.; Clotet, B.; Martinez-Picado, J. Maturation of blood-derived 
dendritic cells enhances human immunodeficiency virus type 1 capture and transmission. J. Virol. 
2007, 81, 7559-7570. 
51.  Izquierdo-Useros, N.; Naranjo-Gomez, M.; Archer, J.; Hatch, S.C.; Erkizia, I.; Blanco, J.; Borras, 
F.E.; Puertas, M.C.; Connor, J.H.; Fernandez-Figueras, M.T.; Moore, L.; Clotet, B.; Gummuluru, 
S.; Martinez-Picado, J. Capture and transfer of HIV-1 particles by mature dendritic cells 
converges with the exosome-dissemination pathway. Blood 2009, 113, 2732-2741. 
52.  Wang, J.H.; Janas, A.M.; Olson, W.J.; KewalRamani, V.N.; Wu, L. CD4 coexpression regulates 
DC-SIGN-mediated transmission of human immunodeficiency virus type 1. J. Virol. 2007, 81, 
2497-2507. Viruses 2010, 2                  
 
 
1716
53.  Cavrois, M.; Neidleman, J.; Kreisberg, J.F.; Greene, W.C. In vitro derived dendritic cells trans-
infect CD4 T cells primarily with surface-bound HIV-1 virions. PloS Pathog. 2007, 3, e4. 
54. Yu, H.J.; Reuter, M.A.; McDonald, D. HIV traffics through a specialized, surface-accessible 
intracellular compartment during trans-infection of T cells by mature dendritic cells. PloS Pathog. 
2008, 4, e1000134. 
55. Fahrbach, K.M.; Barry, S.M.; Ayehunie, S.; Lamore, S.; Klausner, M.; Hope, T.J. Activated 
CD34-derived Langerhans cells mediate transinfection with human immunodeficiency virus.   
J. Virol. 2007, 81, 6858-6868. 
56.  Pelchen-Matthews, A.; Kramer, B.; Marsh, M. Infectious HIV-1 assembles in late endosomes in 
primary macrophages. J. Cell. Biol. 2003, 162, 443-455. 
57.  Deneka, M.; Pelchen-Matthews, A.; Byland, R.; Ruiz-Mateos, E.; Marsh, M. In macrophages, 
HIV-1 assembles into an intracellular plasma membrane domain containing the tetraspanins 
CD81, CD9, and CD53. J. Cell. Biol. 2007, 177, 329-341. 
58.  Welsch, S.; Keppler, O.T.; Habermann, A.; Allespach, I.; Krijnse-Locker, J.; Krausslich, H.G. 
HIV-1 Buds Predominantly at the Plasma Membrane of Primary Human Macrophages. PLoS 
Pathog. 2007, 3, e36. 
59.  Bennett, A.E.; Narayan, K.; Shi, D.; Hartnell, L.M.; Gousset, K.; He, H.; Lowekamp, B.C.; Yoo, 
T.S.; Bliss, D.; Freed, E.O.; Subramaniam, S. Ion-abrasion scanning electron microscopy reveals 
surface-connected tubular conduits in HIV-infected macrophages. PLoS Pathog.  2009,  5, 
e1000591. 
60.  Gousset, K.; Ablan, S.D.; Coren, L.V.; Ono, A.; Soheilian, F.; Nagashima, K.; Ott, D.E.; Freed, 
E.O. Real-time visualization of HIV-1 GAG trafficking in infected macrophages. PLoS Pathog. 
2008, 4, e1000015. 
61.  Frank, I.; Stossel, H.; Gettie, A.; Turville, S.G.; Bess, J.W., Jr.; Lifson, J.D.; Sivin, I.; Romani, N.; 
Robbiani, M. A fusion inhibitor prevents spread of immunodeficiency viruses, but not activation 
of virus-specific T cells, by dendritic cells. J. Virol. 2008, 82, 5329-5339. 
62. Sherer, N.M.; Lehmann, M.J.; Jimenez-Soto, L.F.; Horensavitz, C.; Pypaert, M.; Mothes, W. 
Retroviruses can establish filopodial bridges for efficient cell-to-cell transmission. Nat. Cell Biol. 
2007, 9, 310-315. 
63.  Sowinski, S.; Jolly, C.; Berninghausen, O.; Purbhoo, M.A.; Chauveau, A.; Kohler, K.; Oddos, S.; 
Eissmann, P.; Brodsky, F.M.; Hopkins, C.; Onfelt, B.; Sattentau, Q.; Davis, D.M. Membrane 
nanotubes physically connect T cells over long distances presenting a novel route for HIV-1 
transmission. Nat. Cell Biol. 2008, 10, 211-219. 
64.  Li, Q.; Duan, L.; Estes, J.D.; Ma, Z.M.; Rourke, T.; Wang, Y.; Reilly, C.; Carlis, J.; Miller, C.J.; 
Haase, A.T. Peak SIV replication in resting memory CD4+ T cells depletes gut lamina propria 
CD4+ T cells. Nature 2005, 434, 1148-1152. 
65. Mattapallil, J.J.; Douek, D.C.; Hill, B.; Nishimura, Y.; Martin, M.; Roederer, M. Massive 
infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection. Nature 
2005, 434, 1093-1097. 
66. Veazey, R.S.; DeMaria, M.; Chalifoux, L.V.; Shvetz, D.E.; Pauley, D.R.; Knight, H.L.; 
Rosenzweig, M.; Johnson, R.P.; Desrosiers, R.C.; Lackner, A.A. Gastrointestinal tract as a major 
site of CD4+ T cell depletion and viral replication in SIV infection. Science 1998, 280, 427-431. Viruses 2010, 2                  
 
 
1717
67.  Brenchley, J.M.; Schacker, T.W.; Ruff, L.E.; Price, D.A.; Taylor, J.H.; Beilman, G.J.; Nguyen, 
P.L.; Khoruts, A.; Larson, M.; Haase, A.T.; Douek, D.C. CD4+ T cell depletion during all stages 
of HIV disease occurs predominantly in the gastrointestinal tract. J. Exp. Med.  2004,  200,  
749-759. 
68.  Dillon, S.M.; Robertson, K.B.; Pan, S.C.; Mawhinney, S.; Meditz, A.L.; Folkvord, J.M.; Connick, 
E.; McCarter, M.D.; Wilson, C.C. Plasmacytoid and myeloid dendritic cells with a partial 
activation phenotype accumulate in lymphoid tissue during asymptomatic chronic HIV-1 
infection. J. Acquir. Immune Defic. Syndr. 2008, 48, 1-12. 
69.  Douek, D.C.; Brenchley, J.M.; Betts, M.R.; Ambrozak, D.R.; Hill, B.J.; Okamoto, Y.; Casazza, 
J.P.; Kuruppu, J.; Kunstman, K.; Wolinsky, S.; Grossman, Z.; Dybul, M.; Oxenius, A.; Price, D. 
A.; Connors, M.; Koup, R.A. HIV preferentially infects HIV-specific CD4+ T cells. Nature 2002, 
417, 95-98. 
70.  Brenchley, J.M.; Ruff, L.E.; Casazza, J.P.; Koup, R.A.; Price, D.A.; Douek, D.C. Preferential 
infection shortens the life span of human immunodeficiency virus-specific CD4+ T cells in vivo. 
J. Virol. 2006, 80, 6801-6809. 
64.  Brenchley, J.M.; Ruff, L.E.; Casazza, J.P.; Koup, R.A.; Price, D.A.; Douek, D.C. Preferential 
infection shortens the life span of human immunodeficiency virus-specific CD4+ T cells in vivo. 
J. Virol. 2006, 80, 6801-6809. 
 
© 2010 by the authors; licensee MDPI, Basel, Switzerland. This article is an Open Access article 
distributed under the terms and conditions of the Creative Commons Attribution license 
(http://creativecommons.org/licenses/by/3.0/). 